AI assistant
Sending…
GENETIC TECHNOLOGIES LIMITED — Director's Dealing 2003
Sep 4, 2003
65022_rns_2003-09-04_c7366742-b9e8-41f0-8dc6-c1811446377a.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y
Rule 3.19A.2
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/9/2001.
| Name of entity | GENETIC TECHNOLOGIES LIMITED |
|---|---|
| ABN | 17 009 212 328 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Fred Bart |
|---|---|
| Date of last notice | 12 June 2002 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Direct or indirect interest | Direct and indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Fred Bart controls Security & Equity Resources Limited |
| Date of change | 2 September 2002 |
| No. of securities held prior to change | $26,918,214$ Ordinary shares - Security & Equity Resources Limited - Indirect 500,000 unlisted options exercisable at 61 cents on or before 30 November 2007- Direct |
| Class | Fully paid ordinary shares Unlisted options |
| Number acquired | Nil |
| Number disposed | 1,000,000 Ordinary fully paid shares Option granted to purchaser of 1m shares to acquire a further 1,000,000 ordinary shares at 75 cents each at any time up to 27 August 2005 |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
\$750,000 |
+ See chapter 19 for defined terms.
| No. of securities held after change | 25,918,214 Ordinary shares - Security & Equity Resources Limited - Indirect 500,000 unlisted options exercisable at 61 cents on or before 30 November 2007- Direct |
|---|---|
| Nature of change Example: on-market trade, off-market trade, exercise of options, of securities under dividend reinvestment olan. issue participation in buy-back |
Off-market trade |
Part 2 - Change of director's interests in contracts
| Detail of contract | |
|---|---|
| Nature of interest | |
| Name of registered holder | |
| (if issued securities) | |
| Date of change | |
| No. and class of securities to which | |
| interest related prior to change Note: Details are only required for a contract in |
|
| relation to which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/Consideration | |
| Note: If consideration is non-cash, provide details and an estimated valuation |
|
| Interest after change | |
$+$ See chapter 19 for defined terms.
More from GENETIC TECHNOLOGIES LIMITED
Interim / Quarterly Report
2026
Mar 29
Interim / Quarterly Report
2026
Mar 29
Interim / Quarterly Report
2026
Mar 29
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Board/Management Information
2026
Mar 23
Regulatory Filings
2026
Mar 23
Board/Management Information
2026
Mar 5